openPR Logo
Press release

Lyme Disease Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

10-30-2017 11:22 AM CET | Health & Medicine

Press release from: Pharmaceutical

Lyme Disease Treatment Market - Global Industry Insights,

Lyme disease is an infectious disease, caused due to the bacterium – Borrelia burgdorferi, which is transmitted to humans through bites of infected adult blacklegged ticks. Most human infections are caused by bites of nymphs (immature tick). Ticks can attach to any part of the human body and can transmit the infection, if attached to the host body for 36 to 48 hours. Blacklegged ticks are responsible for spreading Lyme disease in the northeastern, mid-Atlantic, and north-central areas of the U.S. However, western blacklegged ticks spread Lyme disease in the regions along the Pacific Coast. These regions are thus, expected to witness rapid growth of the market for Lyme disease treatment in the near future.

The early symptoms associated with Lyme disease includes fever, headaches, chills, fatigue, muscle and joint aches, swollen lymph nodes, and characteristic skin rash (erythema migrans). According to the Centers for Disease Control and Prevention (CDC), erythema migrans affects around 70% to 80% of infected people, worldwide. However, untreated Lyme disease can lead to further discomfort, which includes intermittent pain in muscles, tendons, joints, and bones, coupled with severe headaches, neck stiffness, arthritis with severe joint pain, swelling in knees, facial palsy, increased heart palpitations or an irregular heartbeat, nerve pain, and inflammation of the brain and spinal cord.

Lyme carditis is a rare complication in Lyme disease, which occurs when infection invades the tissue of the heart. This can interfere with normal heart rhythm resulting in mild, moderate, or severe heart blockage. Patients may experience palpitations, light- headedness, black outs, chest pain, and dyspnea. According to the National Surveillance Data, done by National Notifiable Disease Surveillance System (NNDSS), between 2001 and 2010, Lyme carditis affected around 1% of patients suffering from Lyme disease, in the U.S. Lyme carditis can be treated with intravenous or oral antibiotics, preferably ceftriaxone. However, some patients might require implantation of a temporary or permanent pacemaker, depending upon the severity of infection.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/862

Antibiotics are found to be the most effective treatment for Lyme disease. Patients with early stages of Lyme disease recover rapidly and completely with appropriate antibiotics such as doxycycline, amoxicillin, and cefuroxime axetil. Patients with certain neurological or cardiac illness may be treated with intravenous ceftriaxone. Patients bearing chronic symptoms of Lyme disease for over 6 months, can recover within a few weeks, through oral antibiotic treatment.

According to International Lyme and Associated Disease Society (ILADS), Lyme disease is often difficult to diagnose and treat, resulting in persistent infections. ILADS recommends individualized treatment based on the severity of symptoms, tick-borne coinfections, and patient’s response to treatment. However, no single antibiotic or combination of antibiotics appears to be capable of eliminating the Lyme disease infection. Therefore, the prevailing cases of Lyme disease and large scope to develop the ideal antibiotic for treatment, are expected to boost the Lyme disease treatment market in the near future.

However, prolonged exposure to antibiotics could possibly wipe out beneficial intestinal flora, leading to various health problems. This, in turn, is expected to impose a threat to growth of the Lyme disease treatment market.

The U.S. Food and Drug Administration (FDA), in July 2017, granted fast track designation to the first vaccine for Lyme disease – VLA15, created by Valneva SE – a Europe-based biotech firm, which is engaged in producing commercial vaccines for travelers. The company plans to initiate the phase 2 studies in early 2018. Introduction of new vaccine are further expected to drive growth of the Lyme disease treatment market.

Lyme Disease Treatment Market Taxonomy:

By disease type:

Early Lyme disease (absence of erythema migrans)
Lyme carditis
Lyme arthritis
neurologic Lyme disease
Borrelial lymphocytosis
Post-treatment Lyme Disease Syndrome (PTLDS)

By treatment:

Doxycycline
Amoxicillin
Cefuroxime axetil
Ceftriaxone
Others (azithromycin, clarithromycin, erythromycin)

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/lyme-disease-treatment-market-862

Increasing incidence to drive the Lyme disease treatment market in North America

Globally, North America accounts for largest share of the market, owing to the highest number of Lyme disease cases reported here. According to Centers for Disease Control and Prevention (CDC), around 28,453 confirmed cases of Lyme disease and 9 new cases per 1,00,000 people were recorded in the U.S. during the 2005 - 2015. The European market is also expected to experience rapid growth in the Lyme disease treatment market in near future. According to the 2014 factsheet of European Centre for Disease Prevention and Control (ECDC), prevalence of Lyme disease is steadily increasing.

The major players operating in the Lyme disease treatment market include Lupin Ltd, Mylan N.V., Sun Pharmaceuticals Industries Ltd., Pfizer Inc., G&W Laboratories, Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, GlaxoSmithKline plc., and Hospira Inc.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lyme Disease Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025 here

News-ID: 792783 • Views:

More Releases from Pharmaceutical

Pharmaceutical Market Report 2018 Companies included CCM Pharmaceuticals, Pharmaniaga, Rosemont Pharmaceuticals, Simpor Pharma, Bosch Pharmaceuticals, NOOR VITAMINS and Others
Pharmaceutical Market Report 2018 Companies included CCM Pharmaceuticals, Pharma …
We have recently published this report and it is available for immediate purchase. For inquiry Email us on: jasonsmith@marketreportscompany.com ********* This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
Equine Healthcare Market Global Industry Insights, Trends, 2026
Equine Healthcare Market Global Industry Insights, Trends, 2026
Equine Healthcare refers to the activities and practices aimed for the maintenance of horses. Equine healthcare offers the veterinary services intended for treating horses to enhance their quality of life, develop quality animal food and increase lifespan. The total equine population is directly proportional to the quality of equine healthcare. Equine healthcare includes a number of activities including diagnosis, therapies and supplements for maintaining internal health of horses. The
Novel Drug Delivery System (NDDS) Market - Global Industry Insights
Novel Drug Delivery System (NDDS) Market - Global Industry Insights
Novel Drug Delivery System (NDDS) refers to the formulations, systems to transport pharmaceutical compound in the body, and approaches needed to achieve the desired therapeutic effect. The side effects and slow processing of conventional drug therapy are contributing to the emergence of novel drug delivery system’s concept. Novel ideas based on interdisciplinary approaches controlling the pharmacodynamics, immunogenicity, pharmacokinetics, bio-recognition, and efficiency of drugs were generated. This new system helps in
The Global Anti-suicide Drugs Market was valued at US$ 3,318.3 million in 2015 and is projected to expand at a CAGR of 4.2% during the forecast period 2016-2024
The Global Anti-suicide Drugs Market was valued at US$ 3,318.3 million in 2015 a …
The Global Anti-suicide Drugs Market was valued at US$ 3,318.3 million in 2015 and is projected to expand at a CAGR of 4.2% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Introduction of novel approved drugs, expected to be commercialized post-2020, intended for treatment of suicidal ideation would be a major breakthrough for the global anti-suicide drugs market. Until recently, suicidal ideation has

All 5 Releases


More Releases for Lyme

Lyme Disease - Drug Pipeline Landscape, 2022 | Global Insight Services
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. Diagnosis of Lyme disease involves lab tests to
Lyme Disease Vaccines - Are They Effective?| Valneva, GlaxoSmithKline Plc.
There is currently no Lyme disease vaccine available. LYMERix®, the only vaccine previously marketed in the United States, was withdrawn from the market in 2002 due to a lack of consumer demand. The vaccine's effectiveness deteriorates over time. Lyme Disease Vaccines Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing
Lyme Disease Therapeutics Market Size Statistics, Facts and Figures
Global Lyme Disease Therapeutics Market: Overview Lyme disease is a contagious disease caused by a bacterium species called Borrelia burgdorferi. It is a tick-borne disease caused by transmission of bacteria to humans through the bite of infected ticks. Common indications of Lyme disease include flu-like symptoms, depression, fatigue, and expanding, circular, reddish skin rashes. View Report : https://www.transparencymarketresearch.com/lyme-disease-therapeutics-market.html If left untreated, these symptoms may worsen and can lead to partial or complete
Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs
Lyme Disease Diagnostics Market - Global Industry Insights, Trends, 2026
Lyme disease occurs due to bacterium Borrelia burgdorferi (Bb) and is transmitted to humans through the bite of infected blacklegged ticks. Its general symptoms include fatigue, headache, fever and a skin rash called erythema migrans. The infection can spread to heart, nervous system and joints if left untreated. Centers for Disease Control and Prevention (CDC) recommends a two-step process to diagnose Lyme infection. The first step uses a testing procedure
Lyme Disease Vaccine Market 2017 - Merck, Merial, Zoetis
Market Reports.biz, recently published a detailed market research study focused on the " Lyme Disease Vaccine Market" across the global, regional and country level. The report provides 360° analysis of " Lyme Disease Vaccine Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Lyme Disease Vaccine industry, and estimates the